Your browser doesn't support javascript.
loading
Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.
Goel, Shom; Pernas, Sonia; Tan-Wasielewski, Zhenying; Barry, William T; Bardia, Aditya; Rees, Rebecca; Andrews, Chelsea; Tahara, Rie Kawabori; Trippa, Lorenzo; Mayer, Erica L; Winer, Eric P; Spring, Laura M; Tolaney, Sara M.
Afiliação
  • Goel S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: Shom.goel@petermac.org.
  • Pernas S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medical Oncology, Institut Catala d'Oncologia-H. U. Bellvitge-IDIBELL, Barcelona, Spain.
  • Tan-Wasielewski Z; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.
  • Barry WT; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.
  • Bardia A; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA.
  • Rees R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Andrews C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Tahara RK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Trippa L; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.
  • Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Spring LM; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA.
  • Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: Sara_Tolaney@dfci.harvard.edu.
Clin Breast Cancer ; 19(6): 399-404, 2019 12.
Article em En | MEDLINE | ID: mdl-31235441
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos